Michael V. Knopp, Organizer Friday, 12 May 2006,
10:30 - 12:00 Last
updated 20 February 2009
Overview: This two-hour session will introduce current approaches using
MR to assess non-invasively the response to therapy. The current
strategic focus is to develop and validate imaging as potential
biomarkers or candidate surrogate markers for response assessment, both
in clinical trials as well as personalized therapeutic management.
Educational Objectives: Upon completion of this session, participants should be able to: • Identify opportunities to use MR for
non-invasive assessment of therapy;
• Recognize requirements for standardization of acquisition and
• Apply standardized approaches to use the potential of MR within
clinical use; and
• Explain current concepts in image based assessment.